Rare Disease Day 2021

by Asphalion

3 years ago
Rare Disease Day

On the occasion of Rare Disease Day, at Asphalion we would like to highlight our commitment to the development of new treatments for rare diseases. We actively contribute to bringing treatments to ...

Register now for the Regulatory and Scientific pathways for global advanced therapies medicinal products development (ATMPs) course by LS Academy!

by Asphalion

3 years ago
ATMP, Therapies Medicinal Products Development

Starting next week, on the 16th, and extending for 2 mores sessions on the 18th and 22nd of February, the online training course on Regulatory and Scientific Pathways for Global Advanced Therapies Med...

World Cancer Day 2021

by Asphalion

3 years ago
medicines, cancer, detection, research

Today is World Cancer Day, a day to raise awareness of cancer and to encourage its prevention, detection and treatment. At Asphalion we are committed to the fight against cancer. We have collaborated ...

BREXIT | What’s new for Pharma and Medical Devices

by Asphalion

3 years ago
Medical Devices, pharma industry, Brexit

Providing guidance about Regulatory Affairs and Trade changes in the Pharma and Medical Devices industries

EMA 20th Regulatory Affairs and Pharmacovigilance Conference

by Asphalion

3 years ago
stakeholders, Pharmacovigilance, Regulatory Affairs, Digitalisation

The 20th Regulatory Affairs and Pharmacovigilance conference of Medicines for Europe keeps on providing useful insights of the path ahead.

Curso online: 'Novedades relacionadas con medicamentos en el entorno regulatorio europeo'. 4 y 5 de febrero, 2021

by Asphalion

3 years ago
sistemas telemáticos, normativa, medicamentos

Nuestros expertos Vicente Tur, Regulatory Affairs Director y Ramón Hernández Moratinos, Senior Regulatory Information Specialist, junto a Ana Viñas, Técnico de la AEMPS serán ponentes en el curso...

EMA Network strategy to 2025

by Asphalion

3 years ago
Pharmacovigilance conference, medicines, EMA, Covid-19, Digitalisation

The European Medicines Agency Network Strategy to 2025 was detailed just last week during the 20th Regulatory Affairs and Pharmacovigilance conference.

#AsphaWellbeing: Asphalion´s new well-being programme for employees

by Asphalion

3 years ago
healthy, employees, programme, AsphaWellbeing

The well-being of our employees is front and centre at Asphalion. Lockdown and homeworking have had a significant impact to our lifestyle and taking care of ourselves is essential, especially in these...

Brexit advice: Schedule a meeting with us!

by Asphalion

3 years ago
regulatory, Brexit, business, consulting

Recently, we have received a lot of questions regarding Brexit and the changes it might imply for your business.

Sonia López- New Pharmacovigilance Director at Asphalion

by Asphalion

3 years ago
Pharmacovigilance Practices, Sonia López, pharmaceutical industry, medicinal products

Asphalion’s Board of Directors is pleased to announce the appointment of Sonia López as new Pharmacovigilance Director.

Marta Rayo Lunar- New Scientific and Regulatory Affairs Director at Asphalion

by Asphalion

3 years ago
drug candidates, Marta Rayo Lunar, Regulatory Affairs, Pharmacy

Asphalion’s Board of Directors is pleased to announce the appointment of Marta Rayo Lunar as new Scientific and Regulatory Affairs Director.

BREXIT | Latest updates in Practical guidance for procedures related to Brexit for medicinal products for human use approved via MRP/DCP

by Asphalion

3 years ago
medicinal products, BREXIT, Practical guidance, GMP certificates

As Brexit is quickly coming closer, the CMDh has published an updated version of the Practical guidance for procedures related to Brexit for medicinal products for human use approved via MRP/DCP in...